Navigation Links
Malaria research wins Jake Baum a Young Tall Poppy award

Research aimed at developing drugs that stop malaria parasites from spreading throughout the body has seen Dr Jake Baum, from the Walter and Eliza Hall Institute, named a Young Tall Poppy by the Australian Institute of Policy and Science.

Dr Baum, a senior postdoctoral fellow in the institute's Infection and Immunity division, is investigating the molecular mechanisms that control the malaria parasite's movement.

"Malaria parasites use a unique actin-myosin motor that enables them to literally glide across cell surfaces and enter host cells," Dr Baum said. "The components of this gliding motor are well established yet we still know almost nothing about how motility is regulated."

Dr Baum hopes to identify the critical component that regulates the parasite's movement so that drugs can be developed that stop the parasite from spreading from the body's liver cells into the bloodstream.

"Through the development of drugs that prevent the malaria parasite's movement we hope to contain its spread and therefore prevent or treat malaria disease."

Malaria is one of the world's most prevalent diseases. It causes hundreds of millions of infections each year and is the greatest cause of infant death in large parts of Africa and South East Asia, killing a child every 30 seconds.

Dr Baum was one of 11 Young Tall Poppy winners from Victoria and Tasmania. He was presented with his award on 17 September by the Hon Robyn Parker, Member of the Legislative Council for New South Wales.

The Tall Poppy Campaign was created by the Australian Institute of Policy and Science to recognise and celebrate Australian scientific and intellectual excellence and to encourage younger Australians to follow in the footsteps of outstanding achievers.

Previous Tall Poppy award winners from the Walter and Eliza Hall Institute have been Dr Kylie Mason, Dr Ben Croker, Dr Benjamin Kile and Professors Brendan Crabb, Simon Foote and Doug Hilton.


Contact: Penny Fannin
Walter and Eliza Hall Institute

Related biology news :

1. First genetically-engineered malaria vaccine to enter human trials
2. Vaccine blocks malaria transmission in lab experiments
3. New lead on malaria treatment
4. Bacteria play role in preventing spread of malaria
5. Alzheimers, asthma, cancer, malaria and TB focus of new Singapore grants
6. IVCC and Syngenta start project for novel insecticidal active ingredient for malaria control
7. New hope for advances in treating malaria
8. NIH funds development of resistance-breaking insecticides to reduce malaria transmission
9. Locking parasites in host cell could be new way to fight malaria
10. Malaria immunity trigger found for multiple mosquito species
11. Researchers identify new way the malaria parasite and red blood cells interact
Post Your Comments:
Related Image:
Malaria research wins Jake Baum a Young Tall Poppy award
(Date:11/16/2015)... Nov 16, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced expansion of its TDDI product ... touch controller and display driver integration (TDDI) solutions ... These new TDDI products add to the previously-announced ... TD4302 (WQHD resolution), and TD4322 (FHD resolution) solutions. ...
(Date:11/12/2015)...  Arxspan has entered into an agreement with ... use of its ArxLab cloud-based suite of biological ... will support the institute,s efforts to electronically manage ... internally and with external collaborators. The ArxLab suite ... Institute,s electronic laboratory notebook, compound and assay registration, ...
(Date:11/11/2015)... MedNet Solutions , an innovative SaaS-based eClinical technology company that ... announce that it will be a Sponsor of the ... held November 17-19 in Hamburg , Germany.  ... iMedNet , MedNet,s easy-to-use, proven and affordable eClinical ... able to deliver time and cost savings of up to ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: MNK ), ... has closed the sale of its global contrast media ... Euronext) in a transaction valued at approximately $270 million. ... a total of approximately 1,000 employees spread across the ... Louis area. This entire workforce and the ...
(Date:11/27/2015)... PUNE, India , November 27, 2015 ... --> Growing popularity of companion ... emerging in cancer biomarkers market with pharmaceutical ... develop in-demand companion diagnostic tests. ... --> Complete report on global ...
(Date:11/26/2015)... November 26, 2015 --> ... specializing in imaging technologies, announced today that it has received ... of the Horizon 2020 European Union Framework Programme for Research ... clinical trial in breast cancer. , --> ... --> --> The study aims ...
(Date:11/25/2015)... 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced ... stockholder rights plan (Rights Plan) in an effort to ... (NOLs) under Section 382 of the Internal Revenue Code ... PharmAthene,s use of its NOLs could be substantially limited ... in Section 382 of the Code. In general, an ...
Breaking Biology Technology: